This meta-analysis of 20 studies suggests that GSTO2*N142D may significantly increase the cancer risk in the Caucasian population, particularly for breast cancer, while GSTO1-1 polymorphisms show no significant association to cancer susceptibility. This evidence concerns the gene GSTO2 and breast cancer.